首页> 外国专利> Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble epoxide hydrolase and peroxisome proliferator-activated receptors

Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble epoxide hydrolase and peroxisome proliferator-activated receptors

机译:用可溶性环氧化物水解酶和过氧化物酶体增殖物激活受体的新型双重调节剂治疗糖尿病和代谢综合征

摘要

N-benzylbenzamides that act as dual soluble soluble epoxide hydrolase (sEH)/peroxisome proliferator-activated receptor γ (PPARy) modulators and are useful as medications in the treatment of Metabolic Syndrome (MetS) cluster diseases, including diabetes. Methods of making and using the same are further provided.
机译:N-苄基苯甲酰胺充当双重可溶性可溶性环氧水解酶(sEH)/过氧化物酶体增殖物激活的受体γ(PPARy)调节剂,可用作治疗包括糖尿病在内的代谢综合征(MetS)群疾病的药物。进一步提供了制造和使用它们的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号